Literature DB >> 20428864

Technological innovation in the sentinel node procedure: towards 3-D intraoperative imaging.

Renato A Valdés Olmos, Sergi Vidal-Sicart, Omgo E Nieweg.   

Abstract

Mesh:

Year:  2010        PMID: 20428864     DOI: 10.1007/s00259-010-1468-3

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  6 in total

1.  SPECT-CT and real-time intraoperative imaging: new tools for sentinel node localization and radioguided surgery?

Authors:  Renato A Valdés Olmos; Sergi Vidal-Sicart; Omgo E Nieweg
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01       Impact factor: 9.236

2.  First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECT.

Authors:  Thomas Wendler; Ken Herrmann; Andreas Schnelzer; Tobias Lasser; Joerg Traub; Olivier Kutter; Alexandra Ehlerding; Klemens Scheidhauer; Tibor Schuster; Marion Kiechle; Markus Schwaiger; Nassir Navab; Sibylle I Ziegler; Andreas K Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-31       Impact factor: 9.236

3.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe.

Authors:  D N Krag; D L Weaver; J C Alex; J T Fairbank
Journal:  Surg Oncol       Date:  1993-12       Impact factor: 3.279

4.  Technical details of intraoperative lymphatic mapping for early stage melanoma.

Authors:  D L Morton; D R Wen; J H Wong; J S Economou; L A Cagle; F K Storm; L J Foshag; A J Cochran
Journal:  Arch Surg       Date:  1992-04

5.  Intraoperative radioguidance with a portable gamma camera: a novel technique for laparoscopic sentinel node localisation in urological malignancies.

Authors:  L Vermeeren; R A Valdés Olmos; W Meinhardt; A Bex; H G van der Poel; W V Vogel; F Sivro; C A Hoefnagel; S Horenblas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-14       Impact factor: 9.236

6.  The impact on post-surgical treatment of sentinel lymph node biopsy of internal mammary lymph nodes in patients with breast cancer.

Authors:  Eve Madsen; Pd Gobardhan; V Bongers; M Albregts; Jpj Burgmans; P De Hooge; J Van Gorp; Th van Dalen
Journal:  Ann Surg Oncol       Date:  2007-01-26       Impact factor: 5.344

  6 in total
  7 in total

1.  Changing paradigms in radioguided surgery and intraoperative imaging: the GOSTT concept.

Authors:  John J Zaknun; Francesco Giammarile; Renato A Valdés Olmos; Sergi Vidal-Sicart; Giuliano Mariani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01       Impact factor: 9.236

2.  Portable gamma cameras: the real value of an additional view in the operating theatre.

Authors:  Joan Duch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04       Impact factor: 9.236

Review 3.  New technologies in breast cancer surgery.

Authors:  Marc Thill; Kristin Baumann
Journal:  Breast Care (Basel)       Date:  2012-10       Impact factor: 2.860

4.  Crossing technological frontiers in radioguided intervention.

Authors:  Renato A Valdés Olmos; Sergi Vidal-Sicart; Fijs Wb van Leeuwen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12       Impact factor: 9.236

Review 5.  Sentinel lymph node biopsy in bladder cancer: Systematic review and technology update.

Authors:  Michael A Liss; Jonathan Noguchi; Hak J Lee; David R Vera; A Karim Kader
Journal:  Indian J Urol       Date:  2015 Jul-Sep

6.  Sentinel Lymph Node Detection by 3D Freehand Single-Photon Emission Computed Tomography in Early Stage Breast Cancer.

Authors:  Salih Sinan Gültekin; Ahmet Oğuz Hasdemir; Serhat Tokgöz; Gülay Özgehan; Hakan Güzel; Cüneyt Yücesoy; Emine Öztürk; Ata Türker Arıkök
Journal:  Mol Imaging Radionucl Ther       Date:  2016-06-05

7.  Feasibility of preoperative (125)I seed-guided tumoural tracer injection using freehand SPECT for sentinel lymph node mapping in non-palpable breast cancer.

Authors:  Bas Pouw; Linda J de Wit-van der Veen; Daan Hellingman; Oscar R Brouwer; Marie-Jeanne Tfd Vrancken Peeters; Marcel Pm Stokkel; Renato A Valdés Olmos
Journal:  EJNMMI Res       Date:  2014-05-03       Impact factor: 3.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.